Differentiation, Distribution and γδ T Cell-Driven Regulation of IL-22-Producing T Cells in Tuberculosis
Differentiation, distribution and immune regulation of human IL-22-producing T cells in infections remain unknown. Here, we demonstrated in a nonhuman primate model that M. tuberculosis infection resulted in apparent increases in numbers of T cells capable of producing IL-22 de novo without in vitro Ag stimulation, and drove distribution of these cells more dramatically in lungs than in blood and lymphoid tissues. Consistently, IL-22-producing T cells were visualized in situ in lung tuberculosis (TB) granulomas by confocal microscopy and immunohistochemistry, indicating that mature IL-22-producing T cells were present in TB granuloma. Surprisingly, phosphoantigen HMBPP activation of Vγ2Vδ2 T cells down-regulated the capability of T cells to produce IL-22 de novo in lymphocytes from blood, lung/BAL fluid, spleen and lymph node. Up-regulation of IFNγ-producing Vγ2Vδ2 T effector cells after HMBPP stimulation coincided with the down-regulated capacity of these T cells to produce IL-22 de novo. Importantly, anti-IFNγ neutralizing Ab treatment reversed the HMBPP-mediated down-regulation effect on IL-22-producing T cells, suggesting that Vγ2Vδ2 T-cell-driven IFNγ-networking function was the mechanism underlying the HMBPP-mediated down-regulation of the capability of T cells to produce IL-22. These novel findings raise the possibility to ultimately investigate the function of IL-22 producing T cells and to target Vγ2Vδ2 T cells for balancing potentially hyper-activating IL-22-producing T cells in severe TB.
Vyšlo v časopise:
Differentiation, Distribution and γδ T Cell-Driven Regulation of IL-22-Producing T Cells in Tuberculosis. PLoS Pathog 6(2): e32767. doi:10.1371/journal.ppat.1000789
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000789
Souhrn
Differentiation, distribution and immune regulation of human IL-22-producing T cells in infections remain unknown. Here, we demonstrated in a nonhuman primate model that M. tuberculosis infection resulted in apparent increases in numbers of T cells capable of producing IL-22 de novo without in vitro Ag stimulation, and drove distribution of these cells more dramatically in lungs than in blood and lymphoid tissues. Consistently, IL-22-producing T cells were visualized in situ in lung tuberculosis (TB) granulomas by confocal microscopy and immunohistochemistry, indicating that mature IL-22-producing T cells were present in TB granuloma. Surprisingly, phosphoantigen HMBPP activation of Vγ2Vδ2 T cells down-regulated the capability of T cells to produce IL-22 de novo in lymphocytes from blood, lung/BAL fluid, spleen and lymph node. Up-regulation of IFNγ-producing Vγ2Vδ2 T effector cells after HMBPP stimulation coincided with the down-regulated capacity of these T cells to produce IL-22 de novo. Importantly, anti-IFNγ neutralizing Ab treatment reversed the HMBPP-mediated down-regulation effect on IL-22-producing T cells, suggesting that Vγ2Vδ2 T-cell-driven IFNγ-networking function was the mechanism underlying the HMBPP-mediated down-regulation of the capability of T cells to produce IL-22. These novel findings raise the possibility to ultimately investigate the function of IL-22 producing T cells and to target Vγ2Vδ2 T cells for balancing potentially hyper-activating IL-22-producing T cells in severe TB.
Zdroje
1. ZenewiczLA
YancopoulosGD
ValenzuelaDM
MurphyAJ
StevensS
2008 Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29 947 957
2. WolkK
SabatR
2006 Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17 367 380
3. ZenewiczLA
YancopoulosGD
ValenzuelaDM
MurphyAJ
KarowM
2007 Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27 647 659
4. WolkK
KunzS
WitteE
FriedrichM
AsadullahK
2004 IL-22 increases the innate immunity of tissues. Immunity 21 241 254
5. LiangSC
TanXY
LuxenbergDP
KarimR
Dunussi-JoannopoulosK
2006 Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 2271 2279
6. AujlaSJ
ChanYR
ZhengM
FeiM
AskewDJ
2008 IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14 275 281
7. ZhengY
ValdezPA
DanilenkoDM
HuY
SaSM
2008 Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14 282 289
8. ZhengY
DanilenkoDM
ValdezP
KasmanI
Eastham-AndersonJ
2007 Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 648 651
9. MaHL
LiangS
LiJ
NapierataL
BrownT
2008 IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118 597 607
10. KhaderSA
BellGK
PearlJE
FountainJJ
Rangel-MorenoJ
2007 IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8 369 377
11. NorthRJ
JungYJ
2004 Immunity to tuberculosis. Annu Rev Immunol 22 599 623
12. FlynnJL
ChanJ
2001 Immunology of tuberculosis. Annu Rev Immunol 19 93 129
13. LockhartE
GreenAM
FlynnJL
2006 IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177 4662 4669
14. QiuL
HuangD
ChenCY
WangR
ShenL
2008 Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis 198 1514 1519
15. ScribaTJ
KalsdorfB
AbrahamsDA
IsaacsF
HofmeisterJ
2008 Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 180 1962 1970
16. ChenZW
2005 Immune regulation of gammadelta T cell responses in mycobacterial infections. Clin Immunol 116 202 207
17. SicardH
IngoureS
LucianiB
SerrazC
FournieJJ
2005 In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J Immunol 175 5471 5480
18. OttonesF
DornandJ
NaroeniA
LiautardJP
FaveroJ
2000 V gamma 9V delta 2 T cells impair intracellular multiplication of Brucella suis in autologous monocytes through soluble factor release and contact-dependent cytotoxic effect. J Immunol 165 7133 7139
19. PocciaF
AgratiC
MartiniF
CapobianchiMR
WallaceM
2005 Antiviral reactivities of gammadelta T cells. Microbes Infect 7 518 528
20. PocciaF
BattistiniL
CiprianiB
MancinoG
MartiniF
1999 Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J Infect Dis 180 858 861
21. ShenY
ZhouD
QiuL
LaiX
SimonM
2002 Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 295 2255 2258
22. WangL
KamathA
DasH
LiL
BukowskiJF
2001 Antibacterial effect of human V gamma 2V delta 2 T cells in vivo. J Clin Invest 108 1349 1357
23. SpencerCT
AbateG
BlazevicA
HoftDF
2008 Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity. J Immunol 181 4471 4484
24. HintzM
ReichenbergA
AltincicekB
BahrU
GschwindRM
2001 Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli. FEBS Lett 509 317 322
25. TanakaY
MoritaCT
TanakaY
NievesE
BrennerMB
1995 Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375 155 158
26. AltincicekB
MollJ
CamposN
FoersterG
BeckE
2001 Cutting edge: human gamma delta T cells are activated by intermediates of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis. J Immunol 166 3655 3658
27. BelmantC
EspinosaE
PoupotR
PeyratMA
GuiraudM
1999 3-Formyl-1-butyl pyrophosphate A novel mycobacterial metabolite-activating human gammadelta T cells. J Biol Chem 274 32079 32084
28. WeiH
HuangD
LaiX
ChenM
ZhongW
2008 Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR. J Immunol 181 4798 4806
29. AliZ
ShaoL
HallidayL
ReichenbergA
HintzM
2007 Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-driven antimicrobial and cytotoxic responses of pulmonary and systemic Vgamma2Vdelta2 T cells in macaques. J Immunol 179 8287 8296
30. GongG
ShaoL
WangY
ChenCY
HuangD
2009 Phosphoantigen-activated V{gamma}2V{delta}2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection. Blood 113 837 845
31. HuangD
ShenY
QiuL
ChenCY
ShenL
2008 Immune distribution and localization of phosphoantigen-specific Vgamma2Vdelta2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection. Infect Immun 76 426 436
32. ChenCY
HuangD
WangRC
ShenL
ZengG
2009 A Critical Role for CD8 T cells in a Nonhuman Primate Model of Tuberculosis. PLoS Pathog 5 1000392 doi:10.1371/journal.ppat.1000392
33. ChenY
ShaoL
AliZ
CaiJ
ChenZW
2008 NSOM/QD-based nanoscale immunofluorescence imaging of antigen-specific T-cell receptor responses during an in vivo clonal V{gamma}2V{delta}2 T-cell expansion. Blood 111 4220 4232
34. SanchezFO
RodriguezJI
AgudeloG
GarciaLF
1994 Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun 62 5673 5678
35. ZhangM
LinY
IyerDV
GongJ
AbramsJS
1995 T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 63 3231 3234
36. GongJH
ZhangM
ModlinRL
LinsleyPS
IyerD
1996 Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 64 913 918
37. OuyangW
KollsJK
ZhengY
2008 The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28 454 467
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 2
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Caspase-1 Activation via Rho GTPases: A Common Theme in Mucosal Infections?
- Kaposi's Sarcoma Associated Herpes Virus (KSHV) Induced COX-2: A Key Factor in Latency, Inflammation, Angiogenesis, Cell Survival and Invasion
- IL-1β Processing in Host Defense: Beyond the Inflammasomes
- Reverse Genetics in Predicts ARF Cycling Is Essential for Drug Resistance and Virulence